Testing for all lung cancer mutations at once found cost effective – study
By Julie Steenhuysen CHICAGO (Reuters) – Testing advanced lung cancer patients for all of the possible genetic mutations that could be driving their cancer at once is more cost effective than testing for one or a limited...
Read More